52125-0569 Ondansetron

Product NDC:

52125-0569

Brand Name:

Ondansetron

Generic Name:

Ondansetron

Dosage Form Name:

TABLET, ORALLY DISINTEGRATING

Administration Route:

Oral

Substances:

Name: ONDANSETRON

Strength: 8.0

Unit: mg/1

Packages:

Code: 52125-0569-02

Description:

Effective Date: Nov. 25, 2014

Discontinued: Dec. 12, 2016

Code: 52125-0569-10

Description:

Effective Date: Oct. 10, 2014

Discontinued: Oct. 10, 2014

Code: 52125-0569-14

Description: 2 TABLET, ORALLY DISINTEGRATING in 1 VIAL (52125-569-14)

Effective Date: Oct. 28, 2014

Discontinued: April 8, 2017

Code: 52125-0569-38

Description:

Effective Date: Feb. 27, 2013

Discontinued: May 8, 2016

Code: 52125-0569-52

Description:

Effective Date: Aug. 8, 2013

Discontinued: Aug. 8, 2014

SEER*Rx Category:

Ancillary Therapy

Major Class:

Antiemetic

Minor Class:

5HT3 Receptor Antagonist

Orphan Drug Designation:

Status:

No Longer Used

CanMED and the Oncology Toolbox